These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9697671

  • 1. Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency.
    Samuelsson O, Attman PO, Knight-Gibson C, Larsson R, Mulec H, Weiss L, Alaupovic P.
    J Am Soc Nephrol; 1998 Aug; 9(8):1482-8. PubMed ID: 9697671
    [Abstract] [Full Text] [Related]

  • 2. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency.
    Samuelsson O, Mulec H, Knight-Gibson C, Attman PO, Kron B, Larsson R, Weiss L, Wedel H, Alaupovic P.
    Nephrol Dial Transplant; 1997 Sep; 12(9):1908-15. PubMed ID: 9306342
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
    Attman PO, Samuelsson O, Alaupovic P.
    Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles.
    Bekaert ED, Alaupovic P, Knight-Gibson CS, Franceschini G, Sirtori CR.
    J Lipid Res; 1993 Jan; 34(1):111-23. PubMed ID: 8445335
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of decreasing renal function on lipoprotein profiles.
    Attman PO, Samuelsson O, Alaupovic P.
    Nephrol Dial Transplant; 2011 Aug; 26(8):2572-5. PubMed ID: 21220758
    [Abstract] [Full Text] [Related]

  • 10. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO, Alaupovic P, Tavella M, Knight-Gibson C.
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO, Samuelsson OG, Moberly J, Johansson AC, Ljungman S, Weiss LG, Knight-Gibson C, Alaupovic P.
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [Abstract] [Full Text] [Related]

  • 12. Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.
    Rahman M, Yang W, Akkina S, Alper A, Anderson AH, Appel LJ, He J, Raj DS, Schelling J, Strauss L, Teal V, Rader DJ, CRIC Study Investigators.
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1190-8. PubMed ID: 24832097
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lipoprotein metabolism and renal failure.
    Attman PO, Samuelsson O, Alaupovic P.
    Am J Kidney Dis; 1993 Jun; 21(6):573-92. PubMed ID: 8503411
    [Abstract] [Full Text] [Related]

  • 15. Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.
    Samuelsson O, Attman PO, Knight-Gibson C, Mulec H, Weiss L, Alaupovic P.
    Am J Kidney Dis; 2002 Jan; 39(1):67-75. PubMed ID: 11774104
    [Abstract] [Full Text] [Related]

  • 16. Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure.
    Samuelsson O, Attman PO, Knight-Gibson C, Larsson R, Mulec H, Wedel H, Weiss L, Alaupovic P.
    Nephrol Dial Transplant; 1996 Nov; 11(11):2237-43. PubMed ID: 8941584
    [Abstract] [Full Text] [Related]

  • 17. The plasma levels of homocysteine are elevated in moderate renal insufficiency but do not predict the rate of progression.
    Samuelsson O, Lee DM, Attman PO, Knight-Gibson C, Mullen JK, Larsson R, Mulec H, Weiss L, Alaupovic P.
    Nephron; 1999 Nov; 82(4):306-11. PubMed ID: 10450032
    [Abstract] [Full Text] [Related]

  • 18. Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency.
    Alaupovic P, Attman PO, Knight-Gibson C, Mulec H, Weiss L, Samuelsson O.
    Kidney Int; 2006 May; 69(10):1865-71. PubMed ID: 16572113
    [Abstract] [Full Text] [Related]

  • 19. Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease.
    Attman PO, Alaupovic P, Samuelsson O.
    Kidney Int Suppl; 1999 Jul; 71():S14-7. PubMed ID: 10412728
    [Abstract] [Full Text] [Related]

  • 20. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.
    Dashti N, Alaupovic P, Knight-Gibson C, Koren E.
    Biochemistry; 1987 Jul 28; 26(15):4837-46. PubMed ID: 2822101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.